Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Pieris Pharmaceuticals In...

    NASDAQ: PIRS · Real-Time Price · USD
    13.60
    -2.51 (-15.58%)
    At close: Dec 13, 2024, 10:00 PM

    Pieris Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 42.81M 25.9M 31.42M
    Cost of Revenue
    		 n/a 41.8M 2.78M 2.37M
    Gross Profit
    		 n/a 1.01M 23.12M 29.05M
    Operating Income
    		 n/a -29.76M -43.47M -51.83M
    Interest Income
    		 n/a 1.85M 721K 4K
    Pretax Income
    		 -17.43M -24.54M -33.28M -45.74M
    Net Income
    		 -17.43M -24.54M -31.25M -43.37M
    Selling & General & Admin
    		 5.94M 16.85M 16.39M 16.59M
    Research & Development
    		 8.15M 41.8M 52.98M 66.66M
    Other Expenses
    		 n/a 13.91M -8.17M -3.69M
    Operating Expenses
    		 14.1M 72.57M 61.2M 79.56M
    Interest Expense
    		 -3.89M n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 n/a 72.57M 61.2M 79.56M
    Income Tax Expense
    		 n/a n/a -2.02M -2.37M
    Shares Outstanding (Basic)
    		 2.23M 1.13M 927.15K 806.84K
    Shares Outstanding (Diluted)
    		 2.23M 1.13M 927.15K 806.84K
    EPS (Basic)
    		 -7.83 -21.8 -33.71 -53.75
    EPS (Diluted)
    		 -7.83 -21.8 -33.71 -53.75
    EBITDA
    		 n/a -22.76M -30.5M -43.37M
    EBIT
    		 n/a -24.54M -35.3M -48.15M
    Depreciation & Amortization
    		 n/a 1.78M 2.78M 2.37M

    Add to Watchlist